Florence THUEUX
Florence has a dual experience as an entrepreneur and an investor in the healthcare sector. She has participated in the start-up, development and sell out of several companies, in positions of CFO then CEO and President, in roles of growth structuring, negotiation of deals, architecture of business’ and equity’s partnerships, M&A, strategy and management (Arrow […]
Célia HART
Celia has more than 15 years of private equity experience and has been at Supernova Invest since 2005 in charge of the early-stage team, the healthcare sector and the Supernova 2 fund. Prior to that, she held several senior positions at Cambridge Antibody Technology (Medimmune since its acquisition by Astra Zeneca), one of the UK’s […]
Philippe ARCHINARD
Philippe is Executive Vice President, Technological Innovation and Scientific Partnerships at Institut Mérieux since 2021.He was previously Chairman and Chief Executive Officer of Transgene from 2010 to 2020 and Chief Operating Officer from 2004 to 2020. Prior to joining Transgene, Philippe Archinard was Chief Executive Officer of Innogenetics since 2000. From 1985 to 2000, he […]
Alexandre DHUIÈGE
Alexandre Dhuiège is a recognized French skincare and life sciences executive. A graduate of ISC Paris, he began his career in 1999 with Clarins. In 2002, he joined Institut Esthederm, one of the brands of the French dermo-cosmetics company NAOS, as Key Account Development Manager. He then evolved to the position of Administrative and Financial […]
